Yamamoto et al. showed that the sensitivity of detection of methylation in RASSF1A, GSTP1, or RARβ2 (or a combination of these genes) in the serum of patients with primary and metastatic BC was significantly higher than that involving CEA or CA15-3 [40]. The gene discussed is GSTP1; the disease is breast cancer.